Crystal structures of MMPs in complex with physiological and pharmacological inhibitors

被引:167
作者
Maskos, K [1 ]
机构
[1] Max Planck Inst Biochem, Abt Strukturforsch, D-82152 Martinsried, Germany
关键词
metalloprotease; NIMP; collagenase; latency; dimerization; inhibition; structure;
D O I
10.1016/j.biochi.2004.11.019
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Matrix Metalloproteinases (MMPs) are a family of multidomain zinc endopeptidases that function in the extracellular space or attached to the cell membrane. Their proteolytic activity is controlled by the presence of endogenous inhibitors, the tissue inhibitors of matrix metalloproteinases (TIMPs), alpha-macroglobulin and others. Disruption of the proteinase-inhibitor balance is observed in serious diseases such as arthritis, tumor growth and metastasis, rendering the MMPs attractive targets for drug intervention by pharmacological inhibitors. The determination of MMP structures is of critical importance in order to understand their substrate preferences, dimerization events, and their association with matrix components and inhibitors. Thus, MMP structures may contribute significantly to the development of specific MMP inhibitors, which should allow precise control of individual members of the MMP family without affecting all members or the closely related metalloproteinases such as ADAMs and ADAMTSs. (c) 2005 Elsevier SAS. All rights reserved.
引用
收藏
页码:249 / 263
页数:15
相关论文
共 84 条
[1]   Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes [J].
Atkinson, SJ ;
Crabbe, T ;
Cowell, S ;
Ward, RV ;
Butler, MJ ;
Sato, H ;
Seiki, M ;
Reynolds, JJ ;
Murphy, G .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (51) :30479-30485
[2]   Matrix metalloproteinases, inflammation and atherosclerosis: therapeutic perspectives [J].
Beaudeux, JL ;
Giral, P ;
Bruckert, E ;
Foglietti, MJ ;
Chapman, MJ .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (02) :121-131
[3]   ASTACINS, SERRALYSINS, SNAKE-VENOM AND MATRIX METALLOPROTEINASES EXHIBIT IDENTICAL ZINC-BINDING ENVIRONMENTS (HEXXHXXGXXH AND MET-TURN) AND TOPOLOGIES AND SHOULD BE GROUPED INTO A COMMON FAMILY, THE METZINCINS [J].
BODE, W ;
GOMISRUTH, FX ;
STOCKLER, W .
FEBS LETTERS, 1993, 331 (1-2) :134-140
[4]  
BODE W, 2004, HDB METALLOPROTEINS, P130
[5]   The 1.8-Å crystal structure of a matrix metallaproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition [J].
Brandstetter, H ;
Grams, F ;
Glitz, D ;
Lang, A ;
Huber, R ;
Bode, W ;
Krell, HW ;
Engh, RA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (20) :17405-17412
[6]   Tissue inhibitors of metalloproteinases: evolution, structure and function [J].
Brew, K ;
Dinakarpandian, D ;
Nagase, H .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY, 2000, 1477 (1-2) :267-283
[7]   The second type II module from human matrix metalloproteinase 2:: structure, function and dynamics [J].
Briknarová, K ;
Grishaev, A ;
Bányai, L ;
Tordai, H ;
Patthy, L ;
Llinás, M .
STRUCTURE, 1999, 7 (10) :1235-1245
[8]   Gelatin-binding region of human matrix metalloproteinase-2 -: Solution structure, dynamics, and function of the COL-23 two-domain construct [J].
Briknarová, K ;
Gehrmann, M ;
Bányai, L ;
Tordai, H ;
Patthy, L ;
Llinás, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (29) :27613-27621
[9]   Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin alpha v beta 3 [J].
Brooks, PC ;
Stromblad, S ;
Sanders, LC ;
vonSchalscha, TL ;
Aimes, RT ;
StetlerStevenson, WG ;
Quigley, JP ;
Cheresh, DA .
CELL, 1996, 85 (05) :683-693
[10]   The canonical methionine 392 of matrix metalloproteinase 2 (gelatinase A) is not required for catalytic efficiency or structural integrity - Probing the role of the methionine-turn in the metzincin metalloprotease superfamily [J].
Butler, GS ;
Tam, EM ;
Overall, CM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (15) :15615-15620